{"id":"doi:10.1007/s00262-018-2281-2","kind":"article","title":"CRISPR/Cas9-mediated PD-1 disruption enhances human mesothelin-targeted CAR T cell effector functions","authors":["Wanghong Hu","Zhenguo Zi","Yanling Jin","Gaoxin Li","Kang Shao","Qiliang Cai","Xiaojing Ma","Fang Wei"],"author_count":8,"year":2018,"published":"2018-12-06","venue":"Cancer Immunology Immunotherapy","cited_by":265,"doi":"10.1007/s00262-018-2281-2","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1007/s00262-018-2281-2","archive_url":"https://space-kitty.com/papers/doi:10.1007/s00262-018-2281-2","updated":null,"pmid":"30523370","pmcid":null,"openalex_id":"W2905445906","pdf_url":null,"abstract":null,"abstract_license":null,"license":null,"is_open_access":true,"retracted":false,"peer_reviewed":null,"categories":["CAR-T cell therapy research"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"gene-editing-therapies","name":"CRISPR & Gene-Editing Therapies","domain_slug":"medicine"}],"cited_in_dossiers":[]}